Surfactant, which was first identified in the 1920s is pivotal to lower the surface tension in
alveoli of the lungs and helps to lower the work of breathing and prevents atelectasis …

Surfactant, which was first identified in the 1920s, is pivotal to lower the surface tension in
alveoli of the lungs and helps to lower the work of breathing and prevents atelectasis …

Objective To review the pathophysiology, evaluation, management, and outcomes of
children with inherited disorders of surfactant metabolism due to mutations in the genes …

Lung diseases associated with surfactant-metabolism disorders are a heterogeneous group
of rare diseases. Intra-alveolar accumulation of protein related to surfactant dysfunction …

Respiratory distress is one of the most common clinical presentations in newborns requiring
admission to a Neonatal Intensive Care Unit (NICU). Many of these infants develop …

Surfactants are surface-active agents lowering surface tension in the airways of the lung. It
plays an important role on pulmonary function. Surfactant proteins constitute 10 percent of …

Surfactants are surface-active agents lowering surface tension in the airways of the lung. It
plays an important role on pulmonary function. Surfactant proteins constitute 10 percent of …

Genetic mutations affecting proteins required for normal surfactant protein function are a rare
cause of respiratory disease. The genes identified that cause respiratory disease are …

Surfactants are surface-active agents lowering surface tension in the airways of the lung. It
plays an important role on pulmonary function. Surfactant proteins constitute 10 percent of …

Background: Children's interstitial lung diseases (chILD) comprise a broad spectrum of
diseases. Besides the genetically defined surfactant dysfunction disorders, most entities …